Seres' microbiome therapy reduces infections in stem cell transplant patients, but next steps are unclear
Seres Therapeutics, the biotech company that pioneered one of the first microbiome drugs, a pill containing bacterial spores purified from poop, announced …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
